S&P 500   3,347.74 (-0.04%)
DOW   27,329.19 (-0.21%)
QQQ   274.76 (+0.04%)
AAPL   452.64 (-0.65%)
MSFT   214.92 (-0.66%)
FB   276.83 (+4.35%)
GOOGL   1,512.92 (+0.53%)
AMZN   3,221.46 (-0.11%)
NVDA   456.00 (+0.57%)
CGC   17.25 (-1.54%)
BABA   256.30 (-3.53%)
TSLA   1,480.75 (-0.59%)
MU   48.64 (-0.12%)
GE   6.29 (-0.63%)
AMD   86.05 (-0.76%)
T   29.64 (-0.67%)
F   6.84 (-1.30%)
ACB   10.29 (-0.19%)
GILD   69.00 (+0.28%)
NFLX   501.37 (-1.51%)
DIS   131.65 (+0.63%)
BAC   25.42 (-0.20%)
BA   171.40 (-0.46%)
S&P 500   3,347.74 (-0.04%)
DOW   27,329.19 (-0.21%)
QQQ   274.76 (+0.04%)
AAPL   452.64 (-0.65%)
MSFT   214.92 (-0.66%)
FB   276.83 (+4.35%)
GOOGL   1,512.92 (+0.53%)
AMZN   3,221.46 (-0.11%)
NVDA   456.00 (+0.57%)
CGC   17.25 (-1.54%)
BABA   256.30 (-3.53%)
TSLA   1,480.75 (-0.59%)
MU   48.64 (-0.12%)
GE   6.29 (-0.63%)
AMD   86.05 (-0.76%)
T   29.64 (-0.67%)
F   6.84 (-1.30%)
ACB   10.29 (-0.19%)
GILD   69.00 (+0.28%)
NFLX   501.37 (-1.51%)
DIS   131.65 (+0.63%)
BAC   25.42 (-0.20%)
BA   171.40 (-0.46%)
S&P 500   3,347.74 (-0.04%)
DOW   27,329.19 (-0.21%)
QQQ   274.76 (+0.04%)
AAPL   452.64 (-0.65%)
MSFT   214.92 (-0.66%)
FB   276.83 (+4.35%)
GOOGL   1,512.92 (+0.53%)
AMZN   3,221.46 (-0.11%)
NVDA   456.00 (+0.57%)
CGC   17.25 (-1.54%)
BABA   256.30 (-3.53%)
TSLA   1,480.75 (-0.59%)
MU   48.64 (-0.12%)
GE   6.29 (-0.63%)
AMD   86.05 (-0.76%)
T   29.64 (-0.67%)
F   6.84 (-1.30%)
ACB   10.29 (-0.19%)
GILD   69.00 (+0.28%)
NFLX   501.37 (-1.51%)
DIS   131.65 (+0.63%)
BAC   25.42 (-0.20%)
BA   171.40 (-0.46%)
S&P 500   3,347.74 (-0.04%)
DOW   27,329.19 (-0.21%)
QQQ   274.76 (+0.04%)
AAPL   452.64 (-0.65%)
MSFT   214.92 (-0.66%)
FB   276.83 (+4.35%)
GOOGL   1,512.92 (+0.53%)
AMZN   3,221.46 (-0.11%)
NVDA   456.00 (+0.57%)
CGC   17.25 (-1.54%)
BABA   256.30 (-3.53%)
TSLA   1,480.75 (-0.59%)
MU   48.64 (-0.12%)
GE   6.29 (-0.63%)
AMD   86.05 (-0.76%)
T   29.64 (-0.67%)
F   6.84 (-1.30%)
ACB   10.29 (-0.19%)
GILD   69.00 (+0.28%)
NFLX   501.37 (-1.51%)
DIS   131.65 (+0.63%)
BAC   25.42 (-0.20%)
BA   171.40 (-0.46%)
Log in

OTCMKTS:DCHPFDechra Pharmaceuticals Stock Price, Forecast & News

$38.10
0.00 (0.00 %)
(As of 08/7/2020 09:30 AM ET)
Add
Today's Range
$38.10
Now: $38.10
$38.10
50-Day Range
$34.24
MA: $34.47
$38.10
52-Week Range
$31.60
Now: $38.10
$38.10
VolumeN/A
Average Volume5,190 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolOTCMKTS:DCHPF
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
$38.10
0.00 (0.00 %)
(As of 08/7/2020 09:30 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive DCHPF News and Ratings via Email

Sign-up to receive the latest news and ratings for DCHPF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Dechra Pharmaceuticals (OTCMKTS:DCHPF) Frequently Asked Questions

How has Dechra Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Dechra Pharmaceuticals' stock was trading at $36.45 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, DCHPF stock has increased by 4.5% and is now trading at $38.10.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Dechra Pharmaceuticals?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dechra Pharmaceuticals in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Dechra Pharmaceuticals
.

Has Dechra Pharmaceuticals been receiving favorable news coverage?

News headlines about DCHPF stock have been trending positive on Friday, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Dechra Pharmaceuticals earned a news sentiment score of 2.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future.
View the latest news about Dechra Pharmaceuticals
.

What is Dechra Pharmaceuticals' stock symbol?

Dechra Pharmaceuticals trades on the OTCMKTS under the ticker symbol "DCHPF."

How do I buy shares of Dechra Pharmaceuticals?

Shares of DCHPF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Dechra Pharmaceuticals' stock price today?

One share of DCHPF stock can currently be purchased for approximately $38.10.

This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.